STOCK TITAN

Vertex Pharmaceuticals (NASDAQ: VRTX) reports 978-share Rule 144 resale and insider sales

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Vertex Pharmaceuticals (VRTX) Rule 144 notice reporting planned resale of 978 shares of common stock related to a Restricted Stock Vesting event dated 02/17/2025. The filing also lists recent sales by Joy Liu: 1,385 shares on 01/05/2026 for $621,629.55, 812 shares on 02/12/2026 for $375,282.04, 9,320 shares on 02/13/2026 for $4,557,480.00, and 892 shares on 03/02/2026 for $442,396.32.

Positive

  • None.

Negative

  • None.

Insights

Routine Rule 144 resale notice and recent open-market dispositions by an insider.

The filing lists a small planned resale of 978 shares tied to a Restricted Stock Vesting dated 02/17/2025, plus four reported sales by Joy Liu in early 2026 with aggregate proceeds shown in the filing. The transactions are recorded with sale dates and gross proceeds.

These items are administrative disclosures under Rule 144; the filing does not state any change to capital structure or company proceeds. Subsequent filings would show further disposition details if relevant.

Planned resale 978 shares Restricted Stock Vesting dated 02/17/2025
Sale on 01/05/2026 1,385 shares Gross proceeds <money>$621,629.55</money>
Sale on 02/12/2026 812 shares Gross proceeds <money>$375,282.04</money>
Sale on 02/13/2026 9,320 shares Gross proceeds <money>$4,557,480.00</money>
Sale on 03/02/2026 892 shares Gross proceeds <money>$442,396.32</money>
Rule 144 regulatory
"144: Securities To Be Sold"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Stock Vesting financial
"Restricted Stock Vesting | Issuer | 02/17/2025"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
Gross proceeds financial
"02/13/2026 | 9320 | 4557480.00"
The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the VRTX Form 144 report disclose?

It discloses a planned resale of 978 shares from a restricted stock vesting dated 02/17/2025. It also lists four recent sales by Joy Liu with dates and gross proceeds in early 2026.

Who sold shares according to the VRTX filing?

The filing lists transactions by Joy Liu, showing sales of 1,385, 812, 9,320, and 892 shares on specified early-2026 dates. Each sale includes the reported gross proceeds.

How much did Joy Liu receive from the largest sale listed?

The largest listed sale by Joy Liu was 9,320 shares on 02/13/2026 for $4,557,480.00. The filing shows gross proceeds for each reported sale.

What is the nature of the 978 shares referenced in the filing?

The 978 shares are tied to a Restricted Stock Vesting event dated 02/17/2025 and are identified as resaleable under Rule 144 in this notice.
Vertex Pharmaceuticals Inc

NASDAQ:VRTX

View VRTX Stock Overview

VRTX Rankings

VRTX Latest News

VRTX Latest SEC Filings

VRTX Stock Data

113.44B
253.51M
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON